COVID RELIEF EFFORTS: Transasia donates critical equipment worth more than Rs. 2.25 crores to several state governments- 200 BiPAP machines, 40 cell counters and 30 coagulation analyzers for D Dimer testing

-

 


Transasia Bio-Medicals Ltd., India’s Leading IVD Company has stepped up its efforts to augment the capacity of various state governments to provide timely medical support to COVID-19 patients. 

As India fights the second wave of the pandemic, Transasia has swiftly arranged to provide 200 BiPAP machines along with 40 cell counters and 30 coagulation analyzers, worth more than Rs. 2.25 crores which have been distributed to various COVID-dedicated hospitals across India.

On receiving a request from the Tamil Nadu government, apart from 25 BiPAP machines that provide oxygen support, Transasia also donated 32 units of H 360, three-part differential hematology analyzer, and 5 and 3 units of H 560 and Elite 580 respectively, five-part differential hematology analyzers. These equipments aid in monitoring disease severity in COVID patients.

Similarly, in Delhi, Transasia has provided 30 BiPAP machines along with 30 units of ECL 105, coagulation analyzers. ECL 105 will help Doctors in the estimation of D Dimer and other coagulation factors for monitoring blood clotting in severe COVID patients.

Transasia has already pledged the BiPAP machines to several beneficiaries through the state governments in Maharashtra (Mumbai and Bel-Air Hospital, Panchgani), Delhi, Tamil Nadu, Rajasthan (Jaipur and Ajmer),Uttar Pradesh (Lucknow and Raebareli), Telangana, Karnataka (Chikkamagaluru, Tumkur, Udupi, Chitradurga and Vijayapura),West Bengal, Assam and Agartala.

“The second wave is devastating and is taking a toll on the healthcare system of our country. Transasia remains committed to the health of Indians and through our small effort; we intend to reach out to those severely impacted and in urgent need. This is one of the several few initiatives and we will continue to use our resources and technology, to aid the Central and state health governments.”

-         Suresh Vazirani, Founder Chairman, Transasia-Erba Group

Comments

Post a Comment

Popular posts from this blog

HbA1c: An Important Biomarker in diagnosis and prognosis of diabetes patients

-
Image
  One of the main purposes of laboratory tests is to aid medical reasoning after obtaining the clinical history and performing the physical examination by the laboratory team. To this end, all test execution phases, especially the pre-analytical phase, must be conducted following the technical rigor necessary to ensure patient safety and accurate results, so that the conduction of the patient's prognosis is more assertive. The measurement of HbA1c, when measured in whole blood, by immunoturbidimetric assay, in biochemical equipment from the XL family, such as the XL 200 equipment, plays an important role in the diagnosis of Diabetes. Diabetes is a global endemic with rapidly increasing prevalence in both developing and developed countries. The American Diabetes Association has recommended glycated hemoglobin (HbA1c) as a possible substitute to fasting blood glucose for diagnosis of diabetes. HbA1c is an important indicator of long-term glycemic control with the ability to refle
Read more

Overcome electrolytic analysis challenges with maintenance-free biosensor technology

-
Image
  Find out how to increase the accuracy and reduce the processing time of your routine electrolyte Electrolyte analyzers are routinely used in medical diagnostics to examine physiological conditions within the body. Hospitals and clinical laboratories, as well as treatment sites, rely on electrolyte analyzers to measure the concentration of different ions in the blood, providing important information about the body's electrolyte balance that can be used to detect metabolic imbalances, assess kidney and heart disease and contribute to the early detection of human diseases. However, despite their widespread use, electrolyte analyzers operating with traditional electrode technology are subject to a multitude of challenges, with the need for periodic replacement of electrodes, in particular. In this interview, we speak with Sourav Saha, Product Manager – Critical Care, to learn more about the issues facing clinical labs performing electrolyte analysis and how Erba EC 90, state-of-the
Read more

Amorphous urates: What they are, diagnosis and treatment

-
Image
  Amorphous urates are a type of crystal that varies in colour from yellow to black, identified in the urine test. This can arise due to the cooling of the sample during packaging for transport or due to the acidic pH of the urine, with the values ​​being observed equal to or less than 5.5. Examination of abnormal urine elements and sediment (EAS) can be performed manually or automatically. Automated urinalysis devices available on the market are accurate, reproducible, faster and much less labor intensive (walk-away instruments) than standard manual microscopy. It can be run directly at patient-side without any further sample manipulation (e.g. refrigeration, centrifugation etc.). It has the potential to markedly reduce human factor from interpretation by consistently applying the same algorithm to the analysis of every sample. The Erba Laura XL is an automated device that performs three phases that make up the EAS, from the physical and chemical part to the sedimentoscopy/microscopy,
Read more